Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DAR. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel acid-catalyzed method for Edaravone production offers >99% purity and simplified purification, ensuring cost-effective supply for pharmaceutical manufacturers.
Patent CN111777518A discloses a cost-effective 4-step route for deuterated Phenylethanolamine A, offering high purity for analytical standards and breaking import monopolies.
Novel Cu/Nb2O5 catalyst enables efficient secondary amine production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN109776639B reveals a novel method for synthesizing key arabinoside impurities using phenylhydrazine, offering superior selectivity and cost reduction for pharmaceutical quality control.
Patent CN1622932A details a novel ruthenium catalyst for efficient chiral alcohol resolution. Enables cost reduction in pharmaceutical manufacturing via simplified purification.
Patent CN101817797B details a novel synthesis for 3-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazole carboxamide, offering superior regioselectivity and purity for pharmaceutical quality control.
Patent CN111235123A reveals a novel carbonyl reductase enabling high-substrate loading biocatalysis, offering significant cost reduction and purity advantages for pharmaceutical manufacturing.
Patent CN115304506A reveals a green boron-catalyzed transamidation method. Achieve high-purity secondary amides with reduced costs and simplified supply chains for pharmaceutical manufacturing.
Patent CN100540519C reveals a safer PTC-catalyzed route for 3,4-dimethoxyphenylacetaldehyde. Achieve high purity and cost reduction in API manufacturing with scalable methods.
Patent CN116924916B details a novel catalyst-free reductive amination method offering high selectivity and supply chain stability for pharmaceutical intermediates manufacturing.
Novel 5-step route for Darolutamide reduces complexity vs conventional 10+ step methods, offering cost-effective API intermediate manufacturing solutions.
Patent CN113583992A reveals a novel RsRedAm enzyme for efficient secondary amine synthesis, offering mild conditions and high selectivity for pharmaceutical intermediates.
Patent CN1376659A reveals a safe metal borohydride reduction system for high-purity chiral intermediates, offering significant cost and supply chain advantages.
Novel enzymatic route for Darunavir intermediate (3R, 3aS, 6aR)-hexahydrofuro[2,3-b]furan-3-ol offering high optical purity and industrial scalability.
Novel synthesis route for Regorafenib impurities C and D ensures high purity and cost efficiency for pharmaceutical quality control and supply chain stability.
Novel synthesis of Doramide via enamine cyclization reduces cost and improves purity. Ideal for pharma supply chains seeking scalable API intermediates.
Advanced preparation method for oseltamivir chiral impurities via stereospecific inversion. Ensures reliable supply for pharmaceutical quality control and registration.
Patent CN112250658B details a Vilsmeier-Haack route for Formylated Bicyclol, ensuring high purity for API quality control and supply chain stability.
Novel 6-step route from Naltrexone HCl for high-purity 10α-hydroxynalfurafine. Cost-effective reference standard production with scalable supply chain solutions.
Advanced synthesis of stable isotope labeled tritoquinol hydrochloride via CN112358446B. High-purity API intermediate for doping control and metabolic research with optimized supply chain.